Clinical Trial Update: A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG [Phase 3]

View source ↗

Summary

Phase 3 study assessing safety and efficacy of MC-1 in high-risk coronary artery bypass graft patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemia-reperfusion Injury
• Myocardial Ischemia

Drugs mentioned

• MC-1

Snippet

Sponsor: Medicure | Conditions: Coronary Artery Bypass Graft Surgery, Myocardial Ischemia | Phase 3 | Status: COMPLETED